Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2‐arachidonoyl‐glycerol and its congeners in human …

C Turcotte, AS Archambault, E Dumais… - The FASEB …, 2020 - Wiley Online Library
Abstract The endocannabinoid (eCB) 2‐arachidonoyl‐gycerol (2‐AG) modulates immune
responses by activating cannabinoid receptors or through its multiple metabolites, notably …

[PDF][PDF] Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human …

C Turcotte, AS Archambault, É Dumais, C Martin… - The FASEB …, 2020 - academia.edu
Abstract The endocannabinoid (eCB) 2-arachidonoyl-gycerol (2-AG) modulates immune
responses by activating cannabinoid receptors or through its multiple metabolites, notably …

Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human …

C Turcotte, AS Archambault, É Dumais… - … : Official Publication of …, 2020 - europepmc.org
The endocannabinoid (eCB) 2-arachidonoyl-gycerol (2-AG) modulates immune responses
by activating cannabinoid receptors or through its multiple metabolites, notably eicosanoids …

Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human …

C Turcotte, AS Archambault… - … publication of the …, 2020 - pubmed.ncbi.nlm.nih.gov
The endocannabinoid (eCB) 2-arachidonoyl-gycerol (2-AG) modulates immune responses
by activating cannabinoid receptors or through its multiple metabolites, notably eicosanoids …